MoonLake Immunotherapeutics - Class A — 貸借対照表 (NASDAQ:MLTX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 116.63 M115.84 M76.84 M526.54 M477.93 M424.43 M 負債合計 4.15 M7.9 M8.08 M13.05 M24.54 M119.95 M 純資産合計 5 M-7.06 M68.77 M513.49 M453.39 M304.48 M 負債および純資産合計 116.63 M115.84 M76.84 M526.54 M477.93 M424.43 M 有利子負債合計 58.06 K0———75.71 M 純負債 -1.28 M-666.79 K———-318.26 M

ニュース

Clear Street、IL-17データを受けてMoonlake株の目標株価を引き上げ

Clear Street raises Moonlake stock price target on IL-17 data

Cantor Fitzgeraldが軸性脊椎関節炎の可能性を評価しMoonlake株のレーティングを再確認

Cantor Fitzgerald reiterates Moonlake stock rating on axSpA potential

H.C. Wainwright、治験結果を受けてMoonlake Immunotherapeutics目標株価を40ドルに引き上げ

Moonlake Immunotherapeutics stock price target raised to $40 by H.C. Wainwright on trial results

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript

MoonLake株、軸性脊椎関節炎試験の良好なデータで急騰

MoonLake stock surges on positive axSpA trial data

InvestingProの適正価値判定後、MoonLake株が63%急騰